Font Size: a A A
Keyword [Serous ovarian cancer]
Result: 21 - 40 | Page: 2 of 5
21. A Study Of The Related Markers To Origin Of High Grade Serous Ovarian Cancer
22. Relationships Between Transcription Factor HMBOX1 And The Occurrence And Development Of High-grade Serous Ovarian Cancer
23. Integrin ?2 High Expression Of Ovarian Cancer Ascites Cells Leading To Drug-Resistance Via Upregulating ABCC1
24. The Expression Of BDNF And Ets-1 In Ovarian Cancer And Clinical Significance
25. The Expression Of MicroRNA-506 In Serous Ovarian Cancer And Its Clinical Significance
26. The Expression Of PAK4 In Serous Ovarian Cancer And Its Mechanism
27. FSH,LH,PRL Levels In The Serum Of Patients With Serous Ovarian Cancer And Their Clinical Significance And Their Value Of Combined Detection
28. Association Of The Clinical And Pathological Characteristics And Prognosis With DSG2 Expression In High-grade Serous Ovarian Cancer
29. Preliminary Study On Expression And Correlated Function Of 14-3-3 Beta In Serous Ovarian Cancer
30. Expression And Correlation Of Osteopontin And Annexin A2 In Serous Ovarian Cancer
31. Approach On Treatment Of Platinum-sensitive Relapsed Serous Ovarian Cancer
32. Retrospective Analysis Of Clinical Features Of BRCA Mutations In Patients With Recurrent Serous Ovarian Cancer
33. Function And Mechanism Of MiR-130a In The Development Of Serous Ovarian Cancer
34. The Mechanisms Of FOXD1 Modulating Serous Ovarian Cancer Proliferation And Metastasis
35. Prognostic Analysis In Molecular Subtypes Of Ovarian Cancer And The Underlying Mechanism Of KIAA0101 In Serous Ovarian Cancer
36. The Predictive Values Of KCNN4 And S100A14 For Recurrence In Optimally Debulked Patients With Serous Ovarian Cancer
37. The Effects And Mechanisms Of Hsa-circ-0002755 In High Grade Serous Ovarian Cancer
38. Differential Analysis Of TRNA-derived Small Fragment Expression In Peripheral Blood Of Patients With Advanced Serous Ovarian Cancer And Preliminary Study Of Related Functions And Mechanisms
39. The Sensitizing Effect Of Mir-509-3 On PARP Inhibitors In High-grade Serous Ovarian Cancer Based On PDX Models
40. Expression And Effects Of ROR2 In High-grade Serous Ovarian Carcinoma And Underlying Mechanism
  <<First  <Prev  Next>  Last>>  Jump to